Physician profile
Jonh James Pineda-Bonilla
NPI 1760640429
$55,324.75
in general payments reported to CMS, 2019-2025
15 companies · $4,610 in 2025
The $4,610 reported for 2025 was more than what 90% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $255 · 2021: $299 · 2022: $115 · 2023: $552 · 2024: $49K · 2025: $4,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $2,147 · Food and Beverage: $1,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,025.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,337.50 |
| Travel and Lodging | $2,147.06 |
| Food and Beverage | $1,959.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $53,376.87 | 2019-2025 | Exalt Model D, Overstitch Endoscopic Suturing System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $420.97 | 2023-2024 | Xifaxan |
| Endogastric Solutions, INC | $247.31 | 2023-2024 | Esophyx |
| Olympus Corporation of The Americas | $209.70 | 2024 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Olympus |
| Medtronic, INC. | $190.00 | 2024-2025 | Nexpowder |
| Abbvie INC. | $153.26 | 2019-2023 | |
| Janssen Biotech, INC. | $148.48 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $141.32 | 2025 | Iqirvo |
| Novo Nordisk INC | $110.23 | 2025 | Wegovy |
| Janssen Scientific Affairs, LLC | $99.82 | 2025 | Tremfya |
| Mauna Kea Technologies, INC. | $94.66 | 2019 | |
| Tactile Systems Technology INC | $56.18 | 2022 | |
| Conmed Corporation | $45.45 | 2024 | Conmed Biliary |
| Takeda Pharmaceuticals U.S.A., INC. | $18.23 | 2020 | |
| Axonics, INC. | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonh Pineda-Bonilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.